Tatva Chintan Pharma Chem Board Approves Capacity Expansion & Debt Limit Hike

Tatva Chintan Pharma Chem Limited's Board of Directors met on July 17, 2026, approving the unaudited financial results for Q1 FY27 (standalone and consolidated). Key decisions included the re-appointment of three directors: Mr. Chintan Nitinkumar Shah (Managing Director), Mr. Ajaykumar Mansukhlal Patel (Whole-time Director), and Mr. Shekhar Rasiklal Somani (Whole-time Director), each for a three-year term starting February 1, 2027. The board also greenlit a significant capacity expansion for specialty chemicals at their new Dahej greenfield unit and approved an increase in the company's borrowing limits from ₹300 crore to ₹1,000 crore, subject to shareholder approval.